drugset / Trial / NCT01369277

A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532

NCT01369277

Phase 1 Completed 22 enrolled Pfizer
RandomizedParallel-groupDouble-blind

Summary

This study is to investigate the safety, tolerability and pharmacokinetics of single ascending oral doses of PF-04991532 in Japanese healthy subjects. The secondary objective is to investigate the pharmacokinetics and safety of single ascending oral doses of PF-04991532 in Western healthy subjects and to compare the pharmacokinetics between Japanese and Western healthy subjects.

Timeline

Start
2011-06
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04991532 Small molecule 100 mg Oral
Subject PF-04991532 Small molecule 300 mg Oral
Subject PF-04991532 Small molecule 750 mg Oral